Clinical Engine
Glucommander®
FDA-cleared insulin dosing decision support that supports IV and subcutaneous insulin management across patient acuity levels.
Fast returns
Payback often <3 months across 400+ hospitals.
Enterprise Ready
EHR-integrated, security-forward, Zero Trust approach.
Proven Outcomes
Shorter LOS, fewer readmissions, improved patient safety.
Scale & coverage
IV and subcutaneous (SubQ) with advanced use cases (e.g., diabetic ketoacidosis [DKA], steroid-induced hyperglycemia, tube feeding).
2026 CMS Mandate
Glytec CMS Reporting CareKit
Turnkey preparation for eCQM (starting Jan 1, 2026):
- Summary of the CMS ruling
- Expert implementation guide
- CMS checklist
The Glycemic Management Decision Framework
Build vs. Buy: The Glycemic Management Decision Framework
CIO-aligned
Security, automation, fewer manual steps, and near-term financial results.
Turnkey
FDA cleared, enterprise cloud, Zero Trust, day-one EHR/ICU device interoperability.
DIY Pitfalls
Years of on call IT/endocrinology resourcing, higher cost/risk, inferior outcomes, and unclear roadmap.
Maximum patient impact
Beyond IV-only, covers IV + SubQ and complex scenarios.
Immediate ROI
Documented 6–8× ROI via fewer hypoglycemia events, shorter stays, and reduced readmissions.
Diabetes and Insulin Management Platform
Revolutionizing Glycemic Management
Personalized insulin-dosing decision support at point of care.
Workflow alerts for blood glucose (BG) checks and patient monitoring.
Retrospective metrics to measure and track performance.
Seamless EHR integration (e.g. SmartClick SSO).
Webinar
The Best of The Best Use Glytec
See how Leapfrog “Straight A” hospitals use Glucommander to set themselves apart. Topics include leadership approaches, outcome improvement, and eCQMs.